Rating Rationale
September 03, 2021 | Mumbai
Dr. Agarwals Eye Hospital Limited
Rating Reaffirmed
 
Rating Action
Total Bank Loan Facilities RatedRs.35 Crore
Long Term RatingCRISIL A-/Stable (Reaffirmed)
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has reaffirmed its CRISIL A-/Stable rating on the bank facilities of Dr. Agarwals Eye Hospital Limited (AEHL).

 

The rating reflects the strong operational, technical and management support that AEHL receives from its parent Agarwals Healthcare Limited (AHCL). The ratings also factor in established market position, healthy brand recall in the eye care segment and its healthy financial risk profile. These strengths are partially offset by competition from other hospitals/standalone clinics and geographical concentration risk

Analytical Approach

For arriving at its rating, CRISIL Ratings has applied its framework on notching up for ratings for support received from parent; AHCL

Key Rating Drivers & Detailed Description

Strengths:

  • Strong operational, managerial, and financial support from AHCL: AHCL holds a stake of 71.75 percent in AEHL and will continue to provide full operational, managerial, and technical support over the medium term. CRISIL Ratings takes note of corporate guarantees on behalf of AEHL extended by AHCL, to the company's lenders, which assures payment of obligation.

 

  • Established market position and healthy brand recall: AEHL has a strong presence in eye care majorly in Tamil Nadu, with 22 centers located in Tamil Nadu and one center in Rajasthan. With a long vintage of close to 30 years, the company has built an established market position and healthy brand recall as reflected in turnover of around Rs.140 crore and operating profitability of around 21 percent for fiscal 2021.

 

  • Healthy financial risk profile:  AEHL’s financial risk profile is healthy, as reflected from a strong capital structure and healthy debt protection metrics. The total outside liabilities to tangible networth ratio (TOLTNW) was moderate at around 1.68 times as on March 31, 2021. The TOLTNW is expected to improve to less than 1 time at the end of fiscal 2022.The Debt protection metrics are healthy marked by interest coverage and net cash accrual to total debt ratios at around 4.91 times and 1.05 times for fiscal 2021. In the absence of major debt funded capital expenditure, the financial risk profile is expected to remain strong over the medium term.

 

Weaknesses:

  • Competition from other hospitals/standalone clinics: The company faces competition from other large multi-specialty hospitals, as well as neighborhood eye clinics. Despite well-established hospitals, the company continues to face competition from neighborhood eye clinics for smaller procedures like cataract and from large hospitals for more complex procedures.

 

  • Geographic concentration risk: AEHL’s scale of operations remains moderate, reflected by revenues at Rs.140 crore, for fiscal 2021, deriving most of its revenues from the state of Tamil Nadu. This renders the company to risks relating to geographic concentration.

Liquidity: Strong

AEHL’s liquidity is strong supported by moderate utilisation of bank limits and adequate cash accrual for meeting repayment obligations. The fund based working capital limits of have been utilized at an average of around 70-80 percent, over the last twelve months ended June 2021. AEHL’s cash accrual is expected in the range of around Rs 35-40 crore per annum over the medium term, which shall be adequate to meet maturing term debt repayments of Rs 3 to 4 crore ; annually over the next three years AEHL does not have any major debt funded capital expenditure over the medium term, supporting  its liquidity profile. The group had availed the moratorium from its lenders in line with the measure announced by the Reserve Bank of India (RBI) on payment of instalment of loans and availed the relief in repayment of bank loan instalments for 6 months (March 2020-August 2020) and has not applied for restructuring of its debt. CRISIL Ratings believes AEHL’s liquidity is expected to remain strong over the medium term.

Outlook: Stable

CRISIL Ratings believe AEHL will continue to benefit from strong market position and healthy brand recall over the medium term

Rating Sensitivity factors

Upward factors

  • Improvement in turnover by more than 25 percent, along with improvement in operating profitability to more than 27 percent
  • Geographical diversification in revenue profile.
  • Upgrade in the rating of the parent

 

Downward factors

  • Decline in interest coverage to less than 3 times
  • Larger than expected capex or acquisitions resulting in weakening of financial risk profile
  • Downgrade in the rating of the parent.

About the Company

Incorporated in 1994, AEHL is engaged in the business of providing eye care and related businesses. It is listed on Bombay Stock Exchange. AHCL holds 71.75 percent of the shareholding in AEHL. The company derives around 60 percent of its revenues from surgeries, 15 percent from consultation and the balance from the sale of pharmaceutical and optical products.

Key Financial Indicators

Particulars

Unit

2021

2020

Revenue

Rs.Crore

140

177

Profit After Tax

Rs.Crore

-1

14

Profit After Tax Margin

%

-1

7.7

Adjusted Debt/Adjusted Networth

Times

0.31

0.32

Interest coverage

Times

4.91

5.69

 

Note on complexity levels of the rated instrument:
CRISIL Ratings' complexity levels are assigned to various types of financial instruments. The CRISIL Ratings' complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL Ratings' complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

 

ISIN

Name of instrument

Date of allotment

Coupon

rate (%)

Maturity

date

Issue size (Rs.Cr)

Complexity Levels

Rating assigned

with outlook

NA

Cash Credit

NA

NA

NA

6.0

NA

CRISIL A-/Stable

NA

Proposed Long Term

Bank Loan Facility

NA

NA

NA

29.0

NA

CRISIL A-/Stable

 

 

Annexure - Rating History for last 3 Years
  Current 2021 (History) 2020  2019  2018  Start of 2018
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT 35.0 CRISIL A-/Stable   -- 28-10-20 CRISIL A-/Stable   --   -- --
      --   -- 03-01-20 CRISIL A-/Stable   --   -- --
All amounts are in Rs.Cr.
Annexure - Details of Bank Lenders & Facilities    
Facility Amount (Rs.Crore) Rating
Cash Credit 6 CRISIL A-/Stable
Proposed Long Term Bank Loan Facility 29 CRISIL A-/Stable
Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Criteria for Notching up Stand Alone Ratings of Companies based on Parent Support

Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
 naireen.ahmed@crisil.com

Mohit Makhija
Director
CRISIL Ratings Limited
B:+91 124 672 2000
mohit.makhija@crisil.com


Krishna Ambadasu
Associate Director
CRISIL Ratings Limited
D:+91 44 4905 3123
Krishna.Ambadasu@crisil.com


Kirtana Sainath
Manager
CRISIL Ratings Limited
D:+91 44 4226 3634
Kirtana.Sainath@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ("CRISIL Ratings") is a wholly-owned subsidiary of CRISIL Limited ("CRISIL"). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 




About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide


For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale (each a "Report") that is provided by CRISIL Ratings Limited  (hereinafter referred to as "CRISIL Ratings") . For the avoidance of doubt, the term "Report" includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. Rating by CRISIL Ratings contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way. CRISIL Ratings or its associates may have other commercial transactions with the company/entity.

Neither CRISIL Ratings nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, "CRISIL Ratings Parties") guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Ratings Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL RATINGS' PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL Rating's public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: http://www.crisil.com/ratings/highlightedpolicy.html

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL Ratings you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings Limited is a wholly owned subsidiary of CRISIL Limited.

CRISIL Ratings uses the prefix ‘PP-MLD’ for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011 to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratiings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: www.crisil.com/ratings/credit-rating-scale.html